Sign in
4

Changes in Ownership

Evommune, Inc. Filed Acc 0001551966-25-000007

Director acquired 3,371,001 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Hopfner Robert Lorne · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Owned after D/I
2025-11-07 Conversion : show line 1 in the form +3,026 3,026 I
2025-11-07 Conversion : show line 2 in the form +1,441,032 1,441,032 I
2025-11-07 Conversion : show line 3 in the form +1,632,441 1,632,441 I
2025-11-07 Conversion : show line 4 in the form +294,502 294,502 I

Table II: Derivative

10 lines
Date Transaction Shares Owned after D/I
2025-11-07 Conversion : show line 5 in the form Series Seed Preferred Stock −25,790 0 I
2025-11-07 Conversion : show line 6 in the form Series Seed Preferred Stock −7,145,647 0 I
2025-11-07 Conversion : show line 7 in the form Series Seed Preferred Stock −3,572,816 0 I
2025-11-07 Conversion : show line 8 in the form Series A Preferred Stock −2,582,243 0 I
2025-11-07 Conversion : show line 9 in the form Series A Preferred Stock −7,230,283 0 I
2025-11-07 Conversion : show line 10 in the form Series B Preferred Stock −1,895,260 0 I
2025-11-07 Conversion : show line 11 in the form Series B Preferred Stock −2,104,740 0 I
2025-11-07 Conversion : show line 12 in the form Series C Preferred Stock −313,571 0 I
2025-11-07 Conversion : show line 13 in the form Series C Preferred Stock −313,571 0 I
2025-11-07 Conversion : show line 14 in the form Series C Preferred Stock −2,508,575 0 I
Loading xslF345X05/form4-11122025_091138.xml…